Hot Pap Cataplasma NDC 72988-0007

NDC codes

FDA NDC Directory

Product NDC (as listed)72988-0007Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72988-0007Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
72988-0007-2	72988000702	5 PATCH in 1 PACKAGE (72988-0007-2) / 13.4 g in 1 PATCH (72988-0007-1)Marketed from Mar 29, 2019

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Hot Pap Cataplasma
Generic name (nonproprietary): methyl salicylate, vanillyl nonylamide
Active ingredients: Methyl salicylate — 58.3 mg/13.4gNonivamide — 5 mg/13.4g
Dosage form: Patch
Route: Transdermal
Labeler: Lydia Co., Ltd.
Product type: Over-the-counter drug
Marketing category: Unapproved drug (other)
Marketing start: Mar 29, 2019
Listing expires: Dec 31, 2026
Identifiers: Product ID 72988-0007_ffc8f035-939b-481a-e053-6294a90a5b61SPL ID ffc8f035-939b-481a-e053-6294a90a5b61SPL set ID 85360782-69cc-ba9e-e053-2a91aa0a5431UNII LAV5U5022Y, S846B891OR

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Transdermal products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472988000702 followed by a unit qualifier and the quantity

Package 72988-0007-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 5, 2023.

Indications (excerpt from the label)

Adults and children 12 years of age and over: apply to affected area not more than 3 to 4 times daily. Children under 12 years of age: do not use, consult a doctor For easy application: partially peel back protective film and apply exposed patch to the site of pain. Carefully remove remaining film while pressing patch to skin for secure adhesion.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)